Results 231 to 240 of about 3,106,622 (403)
Improving on Nature: James Travis' Work on Recombinant Human α1-Proteinase Inhibitor. [PDF]
Taylor A.
europepmc +1 more source
Proteinase Specificity and Functional Diversity in Point Mutants of Plasminogen Activator Inhibitor 1 [PDF]
Ann Gils, Paul Declerck
openalex +1 more source
Plasma levels of Human Granulocytic Elastase-alpha-Proteinase Inhibitor Complex (E-alpha1PI) in Leukemia [PDF]
Hiller, E., Jochum, Marianne
core
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren's disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis. [PDF]
Gaggar A +7 more
europepmc +1 more source
Feasibility study of very high aprotinin dosage in polytrauma patients [PDF]
Clasen, C. +4 more
core
Lipid nanoparticles (LNPs) are optimized to co‐deliver Cas9‐encoding messenger RNA (mRNA), a single guide RNA (sgRNA) targeting the endogenous cystic fibrosis transmembrane conductance regulator (CFTR) gene, and homologous linear double‐stranded donor DNA (ldsDNA) templates encoding CFTR.
Ruth A. Foley +12 more
wiley +1 more source
System proteinase/inhibitors in the pathogenesis of experimental kidney tuberculosis
D. S. Esmedlyaevа +4 more
openalex +1 more source

